Merck (MRK) EVP Richard DeLuca Sells Shares

What Happened
Richard R. DeLuca, Executive Vice President & President, Merck Animal Health, sold a total of 6,050 shares of Merck & Co., Inc. (MRK) in open-market transactions on August 6, 2026. The sales were reported as three transactions: 4,945 shares at a weighted-average price of $130.23 (≈ $643,993); 805 shares at a weighted-average price of $131.02 (≈ $105,472); and 300 shares at a weighted-average price of $131.02 (≈ $39,307). Total proceeds across the three disposals were about $788,772. These were sales (not purchases or option exercises), which are often routine.

Key Details

• Transaction date: August 6, 2026 (open-market sales; transaction code S).
• Report filed: August 10, 2026 — filed within the typical 2 business‑day window (timely).
• Prices/ranges (per filing footnotes):
  • 4,945 shares — weighted avg $130.23; trades ranged $130.00–$130.92.
  • 805 shares — weighted avg $131.02; trades ranged $131.00–$131.07.
  • 300 shares — weighted avg $131.02; trades ranged $131.00–$131.03.
    The filer offers to provide a breakdown of quantities at each price on request (per footnotes).
• Shares owned after the transactions: not specified in the provided excerpt of the filing.
• No 10b5-1 plan, option exercise, or tax-withholding notation was indicated in the provided details.

Context

• Sales by executives can be for many reasons (diversification, personal liquidity, tax planning) and do not necessarily reflect the company's outlook; purchases typically carry more weight for bullish signals.
• This filing documents open-market dispositions only; there is no indication here of option exercises, gifts, or awards.